Vaspin inhibits kallikrein 7 by serpin mechanism
John T. Heiker(Helmholtz Centre for Environmental Research), Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences), Michael Stümvoll(IFB Adiposity Diseases), Stephan Schultz(Leipzig University), Nora Klöting(Helmholtz Centre for Environmental Research), E. Bartholomeus Kuettner(Leipzig University), Matthias Blüher(Leipzig University), Norbert Sträter(Leipzig University), Péter Kovács, Matthias Kern(Christian-Albrechts-Universität zu Kiel)
Cited by 166
Related Papers
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Metabolically Healthy Obesity
|Endocrine Reviews|2020|995
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Rare and low-frequency coding variants alter human adult height
|Nature|2017|654